Clinical trials cannot start if the contracts aren't signed, yet site contracting remains a notoriously slow and fragmented process. See how we helped two multinational pharmaceutical companies slash their contract execution time from 75 days to just one week, generating a massive $4M in annual productivity savings along the way.

When an operating model is built entirely on "risk elimination," it almost always results in redundancy, over-processing, and bloated teams. See how transitioning one major pharma company to a modern, integrated risk-based approach unlocked end-to-end efficiency and future-proofed their pipeline.

The US Department of Justice has made it clear that relying on random spot checks to catch clinical trial fraud may soon be viewed as "reckless disregard." With the establishment of the HSU in 2025, proactive data analytics are no longer optional. We built a continuous, AI-driven portfolio monitoring system to keep one life sciences giant ahead of the regulatory curve with an innovative approach to detecting fraud in clinical research, leveraging big data, AI, and techniques borrowed from forensic accounting.